![]() |
Short Contents | Full Contents | Other books NCBI |
|
AHRQ Evidence reports and summaries ![]() 83. Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-97-0001, Task Order No. 06 Prepared by: Southern California-RAND Evidence-based Practice Center, Santa Monica, California Program Directors Paul Shekelle, MD, PhD Sally C. Morton, PhD Project Directors Mary Hardy, MD Ian Coulter, PhD Physician Reviewers Jay Udani, MD Myles Spar, MPH, MD Karen Oda, MD Programmer/Analyst Lara K. Jungvig, BA Statisticians Wenli Tu, MS Marika J. Suttorp, MS Staff Assistants Di Valentine, JD Louis Ramirez, BA Reference Librarian Roberta Shanman, MLS Editor Sydne J. Newberry, PhD AHRQ Publication No. 03-0043 July 2003 ISBN: 1-58763-090-7 ISSN: 1530-4396 U.S. Department of Health and Human Services Tommy G. Thompson, Secretary Office of Public Health and Science Richard H. Carmona, M.D., M.P.H., F.A.C.S., Surgeon General of the United States Agency for Healthcare Research and Quality Carolyn M. Clancy, M.D., Director This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders. Suggested Citation: Shekelle P, Morton S, Hardy M. Effect of Supplemental Antioxidants Vitamin C, Vitamin E, and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease. Evidence Report/Technology Assessment No. 83 (Prepared by Southern California-RAND Evidence-based Practice Center, under Contract No 290-97-0001). AHRQ Publication No. 03-E043. Rockville, MD: Agency for Healthcare Research and Quality. July 2003. This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied. AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakers |